human
heart
diseas
major
caus
death
disabl
varieti
anim
model
cardiac
diseas
develop
better
understand
etiolog
cellular
molecular
mechan
cardiac
dysfunct
novel
therapeut
strategi
anim
model
includ
larg
anim
eg
pig
dog
small
rodent
eg
mous
rat
advantag
genet
manipul
mice
appropri
encourag
develop
novel
mous
model
cardiac
diseas
howev
major
differ
rodent
human
heart
rais
caution
extrapol
result
mous
human
rabbit
mediums
anim
mani
cellular
molecular
characterist
much
like
human
practic
altern
larger
mammal
numer
rabbit
model
cardiac
diseas
discuss
includ
pressur
volum
overload
ischemia
rapidpac
doxorubicin
druginduc
arrhythmia
transgenesi
infect
model
also
lead
assess
therapeut
strategi
may
becom
benefici
human
cardiac
diseas
section
editor
studi
human
cardiovascular
diseas
greatli
facilit
use
wide
varieti
anim
model
small
anim
model
rodent
guinea
pig
hamster
offer
mani
advantag
low
cost
short
gestat
time
short
time
diseas
progress
furthermor
tremend
amount
histor
data
decad
rat
model
cardiovascular
diseas
moreov
develop
genet
modifi
mice
transform
medic
research
allow
investig
overexpress
knockout
knockin
gene
interest
explor
function
consequ
genet
modul
larg
anim
diseas
model
dog
pig
offer
distinct
advantag
larger
heart
provid
consider
amount
tissu
differ
chamber
region
heart
biochem
molecular
studi
hemodynam
assess
imag
easier
heart
larg
enough
chronic
instrument
vivo
cardiac
map
studi
larg
size
allow
assess
humanscal
intervent
rang
left
ventricular
assist
devic
lvad
implant
cardiac
defibril
icd
cardiac
resynchron
therapi
crt
cardiac
abl
approach
moreov
larger
anim
heart
physic
dimens
like
human
heart
larger
size
may
crucial
arrhythmogen
mechan
howev
cost
purchas
cost
per
diem
charg
prohibit
especi
longterm
chronic
studi
diseas
state
intermedi
size
rabbit
offer
sever
potenti
advantag
speci
although
rabbit
heart
smaller
dog
pig
larg
enough
easili
surgic
catheterbas
intervent
much
lower
cost
time
less
expens
dog
time
mani
adult
human
scale
intervent
scale
pediatr
use
assess
eg
pacemak
crt
rabbit
model
benefici
see
surgic
intervent
still
easier
microsurg
approach
rodent
importantli
rabbit
cardiac
physiolog
characterist
similar
human
cardiac
physiolog
mous
rat
inde
cellular
electrophysiolog
ca
transport
rabbit
much
like
human
case
either
rat
mous
particularli
relev
studi
heart
failur
hf
arrhythmia
alter
ion
channel
ca
transport
function
express
thought
contribut
directli
depress
contractil
perform
arrhythmogenesi
particular
mous
rat
ventricular
action
potenti
ap
short
durat
complet
lack
promin
ap
plateau
phase
typic
human
rabbit
mammal
larger
rat
fig
furthermor
main
ionic
current
underli
repolar
greatli
influenc
ap
durat
apd
human
rabbit
delay
rectifi
k
current
kr
ks
channel
present
mous
rat
apd
dictat
almost
entir
transient
outward
current
present
human
rabbit
ventricl
play
minor
role
apd
human
rabbit
notabl
electrophysiolog
characterist
secondari
regul
versu
kr
ks
complet
differ
make
much
quantit
differ
mous
rat
almost
ca
involv
activ
contract
releas
sarcoplasm
reticulum
sr
relax
almost
ca
resequest
sr
via
sr
caatpas
fig
much
like
skelet
muscl
howev
human
rabbit
ventricular
myocyt
consider
larger
fraction
activ
ca
come
via
ca
entri
amount
extrud
beat
electrogen
naca
exchang
control
condit
rabbit
human
ca
involv
excitationcontract
coupl
hf
sr
transsarcolemm
cycl
nearli
equal
fig
c
chang
sr
ca
content
declin
normal
adult
rabbit
rat
ventricular
myocyt
basi
quantit
analysi
ca
remov
flux
sr
caatpas
sr
naca
exchang
ncx
combin
slow
action
plasma
membran
caatpas
sl
caatpas
mitochondri
uniport
mito
basi
data
bassani
et
al
c
rabbit
hf
enhanc
ncx
function
decreas
sr
function
bring
system
equal
contribut
base
data
pogwizd
et
al
human
nonfail
fail
heart
exhibit
similar
balanc
flux
rabbit
action
potenti
record
normal
adult
rabbit
rat
ventricular
myocyt
data
bassani
et
al
indic
k
current
respons
repolar
differ
phase
ks
kr
releas
sr
caatpas
function
naca
exchang
influenc
contractil
function
systol
diastol
arrhythmogenesi
hf
major
fundament
speci
differ
may
crucial
endpoint
phenotyp
also
adaptivemaladapt
mechan
involv
diseas
progress
adult
mous
rat
ventricl
normal
express
mainli
fast
amyosin
isoform
allow
faster
crossbridg
cycl
muscl
shorten
bmyosin
hypertrophi
hf
isoform
switch
bmyosin
adult
human
rabbit
myocardia
express
almost
entir
bmyosin
littl
room
isoform
switch
although
chang
may
still
function
consequ
variou
differ
argument
larg
anim
model
eg
canin
porcin
resembl
human
rabbit
regard
crucial
extrapol
result
mous
rat
heart
context
human
diseas
rest
review
discuss
specif
rabbit
model
heart
diseas
rabbit
model
vascular
diseas
lipid
disord
diabet
mellitu
thyroid
diseas
obes
chronic
hypoxia
address
although
constrain
space
attempt
provid
overview
rang
rabbit
heart
diseas
model
use
along
method
advantag
limit
potenti
see
tabl
arterioven
av
shunt
format
induc
volum
overload
eg
sidebysid
anastamosi
common
carotid
arteri
extern
jugular
vein
lead
cardiac
hypertrophi
littl
data
effect
lv
contractil
function
aortic
regurgit
ar
also
caus
volum
overload
induc
rabbit
aortic
valv
cusp
perfor
cathet
use
transcarotid
approach
sever
ar
lead
left
ventricular
hypertrophi
follow
lv
systol
dysfunct
hf
cours
one
two
year
although
ar
rabbit
develop
hf
repres
advantag
ar
model
speci
dog
consist
manifest
normal
systol
function
review
see
chronic
ar
rabbit
exhibit
myocardi
fibrosi
preced
develop
hf
larg
part
cardiac
fibroblast
produc
abnorm
proport
noncollagen
extracellular
matrix
specif
fibronectin
littl
chang
collagen
synthesi
chronic
av
block
dog
induc
av
nodal
ablat
lead
ventricular
remodel
character
lv
hypertrophi
electr
remodel
similar
model
develop
rabbit
heart
exhibit
electr
remodel
prolong
qt
interv
spontan
torsad
de
point
tdp
bradypac
rabbit
reduc
ks
kr
downregul
mink
herg
radiationinduc
heart
diseas
wwwdrugdiscoverytodaycom
although
hf
uncommon
band
descend
aorta
infant
tendayold
rabbit
model
analog
coarctat
aorta
seen
children
lead
progress
aortic
stenosi
within
six
seven
week
lv
mass
volum
ratio
increas
without
chang
lv
systol
function
decreas
myocyt
contractil
hypertens
induc
left
ventricular
hypertrophi
rabbit
unilater
nephrectomi
combin
either
contralater
renal
arteri
constrict
renal
wrap
exampl
studi
onekidney
oneclip
goldblatt
rabbit
remov
right
kidney
partial
constrict
left
renal
arteri
demonstr
sever
hypertens
increas
lv
mass
diastol
dysfunct
lv
systol
function
preserv
mild
lv
hypertrophi
also
produc
rabbit
onekidney
onewrap
method
studi
chronic
infus
angiotensin
use
induc
hypertens
rv
pressur
overload
also
induc
right
heart
hypertrophi
hf
induc
rabbit
sever
intervent
includ
pulmonari
arteri
constrict
adult
young
rabbit
monocrotalineinduc
pulmonari
hypertens
myocardi
infarct
mi
rabbit
induc
coronari
arteri
occlus
use
model
differ
coronari
anatomi
rabbit
speci
collater
circul
extens
canin
heart
circumflex
suppli
lv
free
wall
domin
left
anterior
descend
lad
coronari
arteri
occlus
margin
branch
circumflex
coronari
arteri
often
use
mi
induct
lead
mild
moder
degre
hf
lv
eject
fraction
rang
studi
ef
low
mi
character
increas
lv
enddiastol
dimens
increas
left
atrial
size
similar
found
lad
infarct
speci
signific
alter
badrenerg
receptor
bar
signal
includ
global
reduct
bar
densiti
reduc
bar
coupl
increas
protein
level
activ
g
region
heterogen
intracellular
ca
handl
impair
synchron
ca
releas
event
throughout
myocyt
addit
chronic
occlus
rabbit
model
myocardi
ischemia
follow
reperfus
use
moreov
rabbit
mi
model
includ
intracoronari
microspher
embol
similar
wellestablish
intracoronari
microembol
model
dog
direct
currentshockinduc
cardiac
muscl
injuri
hibern
myocardium
model
rabbit
develop
exampl
coronari
arteri
ligat
moreov
cellular
model
hibern
myocardium
rabbit
cardiac
myocyt
develop
cocultur
adult
rabbit
cardiomyocyt
cardiac
fibroblast
induc
hibernationlik
dedifferenti
serv
valuabl
tool
studi
cellular
pathway
hibern
myocardium
vitro
rabbit
model
heart
failur
hf
induc
rabbit
heart
sever
approach
mention
volum
pressur
overload
well
mi
occasion
lead
hf
howev
sever
hf
rabbit
model
develop
use
approach
success
anim
speci
doxorubicin
adriamycin
anthracyclin
chemotherapeut
agent
one
prescrib
anticanc
drug
primarili
effect
wide
varieti
hematolog
malign
solid
tumor
howev
cardiotox
major
clinic
problem
cumul
toxic
myocardium
prevent
use
maximum
dose
would
need
optim
treatment
progress
reduct
eject
fraction
seen
cours
therapi
life
threaten
chf
observ
patient
receiv
mgm
prompt
studi
experiment
model
adriamycin
use
experiment
induc
cardiomyopathi
rabbit
model
use
identifi
cardioprotect
agent
could
limit
adriamycin
toxic
also
use
model
nonischem
cardiomyopathi
sever
cardiac
dilat
lv
hypertrophi
decreas
lv
systol
function
progress
irrevers
accompani
fluid
retent
activ
sympathet
nervou
system
reninangiotensin
system
howev
evid
badrenerg
receptor
downregul
occur
advanc
human
hf
cardiotox
due
free
radic
format
lipid
peroxid
ultim
alter
lysosom
mitochondria
sr
sarcolemm
membran
chang
result
activ
hydrolyt
enzym
calcium
overload
reduc
energi
product
patholog
chang
includ
cytosol
vacuol
myofibrillar
loss
typic
adriamycin
cardiotox
patient
differ
observ
form
nonischem
hf
human
eg
idiopath
dilat
cardiomyopathi
idcm
longstand
hypertens
valvular
heart
diseas
limit
includ
variabl
degre
lv
dysfunct
produc
undesir
bone
marrow
gi
toxic
highdos
catecholamin
isoproterenol
epinephrin
repetit
infus
induc
cardiomyopathi
rabbit
character
lv
dilat
hypertrophi
depress
systol
function
high
mortal
rate
rapid
pace
induc
hf
tachycardiainduc
hf
describ
patient
longstand
tachyarrhythmia
atrial
fibril
af
rapid
ventricular
respons
rapid
pace
whether
ventricular
atrial
use
induc
hf
sever
speciesmost
commonli
dog
also
pig
rabbit
rapid
ventricular
pace
rabbit
induc
hf
character
cardiac
enlarg
systol
dysfunct
ventricular
myocyt
exhibit
contractil
dysfunct
intermedi
size
rabbit
allow
implant
standard
human
pacemak
intrins
heart
rate
rabbit
rang
beatsmin
pace
rate
rang
beatsmin
requir
hf
develop
cours
two
five
week
character
dyspnea
appetit
loss
bodi
weight
loss
chronic
pace
lead
progress
predict
timedepend
reduct
lv
systol
function
geometri
allow
studi
molecular
cellular
event
develop
chronic
hf
develop
hf
associ
reduc
respons
inotrop
stimulu
decreas
myocyt
contractil
neurohumor
activ
chang
ca
homeostat
mechan
consist
human
hf
includ
decreas
ca
transient
amplitud
ltype
ca
channel
activ
serca
express
howev
yao
et
al
report
decreas
naca
exchang
current
pace
hf
rabbit
contrast
studi
canin
pace
hf
show
enhanc
ncx
activ
ca
minim
buffer
pace
hf
model
speci
lv
systol
function
return
normal
within
approxim
one
week
follow
cessat
pace
although
adenyl
cyclas
respons
agonist
take
two
week
badrenerg
receptor
densiti
take
four
week
return
normal
moreov
lv
dilat
dysfunct
associ
myocardi
cellular
hypertrophi
chang
lv
myocardi
structur
similar
clinic
hf
human
caus
ischem
hypertens
heart
diseas
model
nonetheless
provid
import
inform
regard
pathophysiolog
fail
heart
includ
electr
remodel
abnorm
intracellular
ca
cycl
exercis
train
hf
mani
rabbit
heart
diseas
model
provid
investig
hypertrophi
andor
fail
myocardium
studi
alter
contractil
dysfunct
myocardi
energet
gene
express
howev
studi
arrhythmogenesi
fail
heart
model
limit
fact
rabbit
model
truli
arrhythmogen
fact
even
one
consid
anim
model
hf
larg
small
model
exhibit
sever
contractil
dysfunct
spontan
occur
induc
ventricular
arrhythmia
combin
volum
overload
ar
pressur
overload
aortic
constrict
sever
week
later
consist
lead
hf
much
either
volum
pressur
overload
alon
demonstr
hf
rabbit
exhibit
sever
depress
lv
function
lvh
increas
hwbw
spontan
occur
vt
initi
nonreentr
mechan
trigger
activ
incid
sudden
death
also
show
hf
rabbit
myocyt
exhibit
contractil
dysfunct
decreas
sr
ca
load
associ
alter
intracellular
ca
handl
ncx
ryr
preserv
serca
preserv
bar
respons
enhanc
b
ar
respons
decreas
ion
current
ks
activ
catecholamin
transient
inward
current
ti
initi
delay
depolar
dad
downregul
dephosphoryl
main
ventricular
gap
junction
protein
increas
express
activ
camkii
increas
ryr
phosphoryl
sr
ca
leak
mani
find
valid
focus
studi
fail
human
heart
includ
map
studi
show
focal
nonreentr
mechan
underli
vt
patient
nonischem
hf
ncx
upregul
preserv
serca
larg
subset
human
hf
patient
enhanc
b
adrenerg
respons
fail
human
cardiac
myocyt
downregul
dephosphoryl
human
hf
ischem
nonischem
studi
hf
model
demonstr
addit
insight
arrhythmogenesi
sinu
node
dysfunct
hf
effect
acut
ischemia
superimpos
chronic
hf
thu
find
model
provid
import
new
insight
human
hf
arrhythmogen
rabbit
model
nonischem
hf
technic
challeng
take
month
develop
similar
rabbit
myocardium
human
myocardium
valid
studi
human
indic
model
provid
import
insight
contractil
dysfunct
arrhythmogen
fail
heart
tdp
polymorph
ventricular
tachycardia
occur
set
prolong
qt
interv
caus
sever
pharmaceut
agent
primarili
inhibit
kr
rapid
compon
inward
rectifi
potassium
current
kr
tdp
difficult
model
experiment
anim
mous
rat
lack
ap
plateau
kr
less
use
anim
model
arena
carlsson
et
al
first
develop
vivo
model
tdp
anesthet
aadrenoreceptor
aar
stimul
rabbit
methoxamin
plu
class
iii
antiarrhythm
clofilium
model
use
extens
sever
group
minor
modif
test
druginduc
tdp
understand
underli
electrophysiolog
mechan
vol
drug
discoveri
today
diseas
model
cardiovascular
diseas
model
wwwdrugdiscoverytodaycom
develop
novel
antiarrhythm
approach
tdp
remain
unclear
aar
stimul
facilit
tdp
induct
could
involv
increas
ca
elev
blood
pressur
reflex
vagal
nerv
activ
myocardi
failur
rabbit
induc
coronari
arteri
ligat
also
use
model
predict
develop
tdp
af
studi
isol
rabbit
atria
prepar
provid
key
insight
mechan
af
role
atrial
dilat
rabbit
model
heart
diseas
use
studi
atrial
conduct
atrial
fibril
chronic
volum
overload
av
shunt
format
slow
atrial
conduct
enhanc
induct
atrial
tachycardia
af
howev
rabbit
ventricular
tachypacinginduc
hf
exhibit
atrial
fibrosi
enhanc
atrial
fibril
induc
burst
pace
transgen
mice
provid
import
insight
cellular
physiolog
small
size
murin
heart
limit
easi
assess
function
preclud
assess
humans
intervent
pace
crt
defibril
howev
past
decad
transgen
rabbit
develop
combin
valu
transgen
approach
overexpress
knockout
key
gene
previous
restrict
mous
larger
anim
size
scale
physiolog
rabbit
transgen
rabbit
model
creat
date
includ
long
qt
syndrom
hypertroph
cardiomyopathi
g
sa
overexpress
phospholamban
overexpress
case
find
transgen
rabbit
appear
differ
transgen
mice
exampl
transgen
rabbit
overexpress
g
protein
g
sa
develop
cardiomyopathi
like
transgen
mous
counterpart
phospholamban
overexpress
transgen
rabbit
normal
cardiac
function
respons
badrenerg
stimul
unlik
transgen
mous
model
find
might
aris
speci
differ
compensatori
chang
andor
speci
differ
cellular
physiolog
rabbit
calcium
handl
ion
channel
physiolog
closer
human
observ
mous
expens
time
develop
transgen
rabbit
limit
advanc
field
transgen
rabbit
offer
import
insight
cardiac
physiolog
moreov
addit
induc
cardiac
diseas
state
pressur
overload
mi
hf
provid
novel
insight
contractil
dysfunct
cardiac
remodel
arrhythmogenesi
infecti
diseas
affect
heart
stimul
sever
experiment
model
rabbit
myocard
hf
dilat
cardiomyopathi
induc
rabbit
infect
virus
coronaviru
coxsacki
viru
fungi
cryptococcu
parasit
toxoplasmosi
bacteria
streptococci
diphtheria
chronic
chaga
diseas
produc
rabbit
inocul
virul
strain
trypanosoma
cruzi
character
biventricular
biv
dilat
hypertrophi
apic
aneurysm
interstiti
fibrosi
focal
myocard
bacteri
endocard
produc
rabbit
sever
bacteri
pathogen
includ
streptococcu
enterococcu
staphylococcu
although
focu
studi
predominantli
respons
antimicrobi
therapi
model
provid
insight
pathogenesi
nativ
valv
prosthet
valv
endocard
human
sepsi
affect
cardiac
function
endotoxininduc
cardiomyopathi
induc
infus
bacteri
lipopolysaccharid
radiat
also
induc
acut
myocardi
lesion
typic
pancard
inflammatori
exud
follow
latent
phase
eventu
myocardi
pericardi
fibrosi
studi
rabbit
also
shown
radiat
enhanc
adriamycin
cardiotox
discuss
larg
number
rabbit
model
heart
diseas
finish
review
brief
discuss
model
use
develop
novel
therapeut
approach
heart
diseas
drug
therapi
differ
pharmacolog
agent
therapi
hf
use
wide
rang
rabbit
heart
model
primarili
infarct
combin
pressur
volum
overload
model
degre
pacinginduc
adriamycininduc
hf
cardiac
abl
therapi
rabbit
heart
limit
small
size
vivo
studi
use
current
util
ablat
cathet
howev
isol
perfus
rabbit
heart
use
character
effect
radiofrequ
ablat
atrium
ventricl
av
node
conduct
underli
anatomi
crt
also
known
biv
pace
begin
appli
rabbit
model
mi
recent
studi
shown
biv
pace
attenu
lv
dilat
systol
dysfunct
electr
remodel
icd
use
rabbit
model
date
howev
vf
induc
vf
threshold
assess
vivo
rabbit
heart
well
langendorffperfus
rabbit
heart
gene
therapi
approach
use
rabbit
model
heart
diseas
direct
intramuscular
inject
viral
vector
rabbit
lv
myocardium
simplest
approach
limit
local
transgen
express
well
traumat
effect
needl
inject
myocardi
gene
deliveri
approach
rabbit
initi
involv
thoracotomybas
approach
deliveri
adenovir
transgen
either
ex
vivo
retrograd
intracoronari
deliveri
donor
heart
heterotop
heart
transplant
model
lv
caviti
inject
ascend
aorta
crossclamp
howev
noninvas
techniqu
percutan
subselect
coronari
arteri
catheter
result
effici
deliveri
transgen
ventriclespecif
target
particular
coronari
arteri
catheter
koch
colleagu
use
approach
demonstr
adenovir
gene
transfer
overexpress
b
adrenerg
receptor
barkct
peptid
inhibitor
badrenerg
receptor
kinas
rabbit
mi
model
enhanc
contractil
function
badrenerg
receptor
respons
delay
onset
hf
studi
rabbit
includ
explor
adenovir
gene
transfer
sodiumcalcium
exchang
ncx
fibroblast
growth
caspas
inhibitor
norepinephrin
transport
extracellular
superoxid
dismutas
antiapotot
factor
cell
therapi
approach
test
rabbit
heart
exampl
recent
studi
includ
skelet
myoblast
transplant
infarct
rabbit
heart
autolog
stem
cell
transplant
doxorubicininduc
nonischem
hf
ideal
model
heart
diseas
everi
model
util
advantag
disadvantag
rabbit
use
develop
model
wide
varieti
human
diseas
includ
pressur
overload
volum
overload
combin
pressur
volum
overload
pacinginduc
hf
toxic
cardiomyopathi
toxic
cardiomyopathi
mi
transgen
rabbit
model
transgen
rabbit
model
heart
diseas
develop
sever
human
diseas
way
rabbit
model
human
heart
diseas
offer
distinct
advantag
rodent
larg
anim
dog
pig
term
intermedi
size
intermedi
cost
similar
human
physiolog
provid
novel
insight
human
cardiac
diseas
